Baoji Central Hospital

Baoji 721008

0 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling